FDA 483 - Alcon Research, LLC - April 25, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Alcon Research, LLC in Irvine, CA, a medical device manufacturer, identified a significant deficiency in their corrective and preventive action (CAPA) system. The firm closed a CAPA related to nonconforming raw material (flash drive data for a component) without conducting an effectiveness check or verifying that the corrective action adequately addressed the root cause. This lapse is concerning as the risk management report indicates a possible patient risk of retinal detachment.
ID · e34ae4f6-4105-4e62-9e05-71d5540be3f3